Is Throat Cancer a Head and Neck Cancer?
Title: Is Throat Cancer a Head and Neck Cancer?Category: Diseases and ConditionsCreated: 5/17/2022 12:00:00 AMLast Editorial Review: 5/17/2022 12:00:00 AM (Source: MedicineNet Cancer General)
Source: MedicineNet Cancer General - May 17, 2022 Category: Cancer & Oncology Source Type: news
Most smokers with head and neck cancer STILL puffed on cigarettes two years after treatment
Scientists at the University of Minnesota found of the 61 patients who were still alive two years after treatment, as many as 38 - or 60 percent - were still smokers. (Source: the Mail online | Health)
Source: the Mail online | Health - May 12, 2022 Category: Consumer Health News Source Type: news
F.D.A. Authorizes Underwear to Protect Against S.T.I.s During Oral Sex
It ’s the first time underwear has been authorized for this purpose, and it provides a new choice for protection where the few options have been unpopular. (Source: NYT Health)
Source: NYT Health - May 12, 2022 Category: Consumer Health News Authors: Pam Belluck Tags: Sex Head and Neck Cancer Lingerie and Underwear Sexually Transmitted Diseases Women and Girls Mouth Vagina Human Papillomavirus (HPV) Food and Drug Administration your-feed-science your-feed-healthcare Source Type: news
Is Nasopharyngeal Cancer Head and Neck Cancer?
Title: Is Nasopharyngeal Cancer Head and Neck Cancer?Category: Diseases and ConditionsCreated: 5/12/2022 12:00:00 AMLast Editorial Review: 5/12/2022 12:00:00 AM (Source: MedicineNet Cancer General)
Source: MedicineNet Cancer General - May 12, 2022 Category: Cancer & Oncology Source Type: news
Head and Neck Cancer Patients Call for Improvements in Care Head and Neck Cancer Patients Call for Improvements in Care
Patients with head and neck cancer have the highest rates of emergency department use and hospitalization during treatment, and also the highest rates of psychological distress.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - May 12, 2022 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news
FDA rejects Peninsula biotech's cancer drug — at least for now
The company, working with its partner in China, plans to ask the FDA in August to approve the drug against a type of head-and-neck cancer. (Source: bizjournals.com Health Care News Headlines)
Source: bizjournals.com Health Care News Headlines - May 2, 2022 Category: Health Management Authors: Ron Leuty Source Type: news
Ambient Dirty Air May Put Some People at Higher Risk for Head and Neck Cancers
(MedPage Today) -- DALLAS -- Living in areas with high levels of ambient air pollution may be a risk factor for some head and neck (H&N) cancers, a researcher said here.
In a study that linked data from the Illinois Department of Public... (Source: MedPage Today Public Health)
Source: MedPage Today Public Health - May 1, 2022 Category: American Health Source Type: news
Consumer Health: 4 types of head and neck cancers
April is Head and Neck Cancer Awareness Month, which makes this a good time to learn about four types of cancer that affect these areas of the body. Head and neck cancers account for nearly 4% of all cancers in the U.S., according to the National Cancer Institute. These cancers are more than twice as common among men as women, and are diagnosed more often among people over 50. Among the many types of head… (Source: News from Mayo Clinic)
Source: News from Mayo Clinic - April 28, 2022 Category: Databases & Libraries Source Type: news
Which Drug Is Used As a Targeted Therapy for Head and Neck Cancer?
Title: Which Drug Is Used As a Targeted Therapy for Head and Neck Cancer?Category: Diseases and ConditionsCreated: 4/27/2022 12:00:00 AMLast Editorial Review: 4/27/2022 12:00:00 AM (Source: MedicineNet Cancer General)
Source: MedicineNet Cancer General - April 27, 2022 Category: Cancer & Oncology Source Type: news
Mayo Clinic Q & amp;A podcast: Advances in oral cancer treatment, reconstruction
Oral cancer refers to cancers that originate in the mouth, tongue and back of the throat. Treatment options, which can vary based on the cancer's location and stage, include surgery, radiation and chemotherapy. The use of anatomic modeling and 3D printing have led to advances in surgical treatments for oral cancer. "One of the advances that we've seen in the last 20 or 30 years in the treatment of head and neck cancers certainly has… (Source: News from Mayo Clinic)
Source: News from Mayo Clinic - April 26, 2022 Category: Databases & Libraries Source Type: news
Mayo Clinic Minute: Improved treatments for head and neck cancer
April is Sexually Transmitted Infections Awareness Month. About 70% of cancers in the oropharynx, which includes the tonsils, soft palate and base of the tongue, are linked to the HPV virus, according to the Centers for Disease Control and Prevention. So it's important to talk to your health care team about the HPV vaccine, especially if you are 26 years old or younger. In addition to the importance of the HPV vaccine, you can lower… (Source: News from Mayo Clinic)
Source: News from Mayo Clinic - April 25, 2022 Category: Databases & Libraries Source Type: news
CHMP recommends EU approval of Roche ’s Tecentriq as adjuvant treatment for a subset of people with early-stage non-small cell lung cancer
In the Phase III IMpower010 trial, adjuvant Tecentriq reduced the risk of disease recurrence or death by 57% in people with PD-L1 high resectable Stage II-III NSCLC compared with best supportive careMore than half of people with early-stage NSCLC experience disease recurrence following surgery,1 and most of these recurrent tumours are metastatic, making them incurable2-7If approved, Tecentriq will be the first and only cancer immunotherapy available for certain people with early-stage NSCLC in EuropeBasel, 22 April 2022 - Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced that the European Medicines Agency ’s (EMA) Commi...
Source: Roche Media News - April 22, 2022 Category: Pharmaceuticals Source Type: news
CHMP recommends EU approval of Roche ’s Tecentriq as adjuvant treatment for a subset of people with early-stage non-small cell lung cancer
In the Phase III IMpower010 trial, adjuvant Tecentriq reduced the risk of disease recurrence or death by 57% in people with PD-L1 high resectable Stage II-III NSCLC compared with best supportive careMore than half of people with early-stage NSCLC experience disease recurrence following surgery,1 and most of these recurrent tumours are metastatic, making them incurable2-7If approved, Tecentriq will be the first and only cancer immunotherapy available for certain people with early-stage NSCLC in EuropeBasel, 22 April 2022 - Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced that the European Medicines Agency ’s (EMA) Commi...
Source: Roche Investor Update - April 22, 2022 Category: Pharmaceuticals Source Type: news
Dracen Pharmaceuticals announces two presentations at the American...
Data support that sirpiglenastat (DRP-104) has therapeutic potential in targeting KEAP1-mutant lung cancer as well as squamous cell carcinoma of the head and neck(PRWeb April 08, 2022)Read the full story at https://www.prweb.com/releases/2022/4/prweb18601225.htm (Source: PRWeb: Medical Pharmaceuticals)
Source: PRWeb: Medical Pharmaceuticals - April 8, 2022 Category: Pharmaceuticals Source Type: news
Mixed Message for Ultrasound in High-Risk Cutaneous Head and Neck Cancer
(MedPage Today) -- Ultrasound outperformed baseline clinical assessment for detection of lymph node metastasis in patients with high-risk cutaneous squamous cell carcinoma (SCC) of the head and neck, a retrospective Dutch study showed.
Imaging... (Source: MedPage Today Dermatology)
Source: MedPage Today Dermatology - March 18, 2022 Category: Dermatology Source Type: news
